|
CSDAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.170600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.228200E-04 |
| Normal-vs-Stage2 |
7.109800E-01 |
| Normal-vs-Stage3 |
1.958520E-03 |
| Normal-vs-Stage4 |
2.475900E-03 |
| Stage1-vs-Stage2 |
1.074030E-02 |
| Stage1-vs-Stage3 |
7.976200E-01 |
| Stage1-vs-Stage4 |
5.638600E-01 |
| Stage2-vs-Stage3 |
1.751580E-02 |
| Stage2-vs-Stage4 |
1.455720E-02 |
| Stage3-vs-Stage4 |
7.339400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.8668000000024E-05 |
| Normal-vs-AfricanAmerican |
2.091900E-02 |
| Normal-vs-Asian |
1.495600E-03 |
| Caucasian-vs-AfricanAmerican |
3.473000E-01 |
| Caucasian-vs-Asian |
5.087800E-01 |
| AfricanAmerican-vs-Asian |
6.966800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.683600E-02 |
| Normal-vs-Female |
9.60030000000112E-05 |
| Male-vs-Female |
1.256150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09289999999474E-05 |
| Normal-vs-Age(41-60Yrs) |
2.861600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.263200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.845800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.067700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.941900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.797000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.210420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.210200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.260800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.197800E-01 |
| Classical-VS-Follicular |
2.22044604925031E-16 |
| Classical-VS-Other |
1.304390E-01 |
| Classical-VS-Normal |
1.53580000050724E-07 |
| Tall-VS-Follicular |
8.18439999994425E-07 |
| Tall-VS-Other |
4.928000E-02 |
| Tall-VS-Normal |
3.440200E-04 |
| Follicular-VS-Other |
2.816200E-01 |
| Follicular-VS-Normal |
2.112500E-02 |
| Other-VS-Normal |
9.782200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.054360E-01 |
| Normal-vs-N1 |
5.96880000000022E-05 |
| N0-vs-N1 |
3.119100E-03 |
|
|
